Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paiqin vs Jinyouli for prevention of chemotherapy-induced neutropenia
CTR20140464Phase 2Completed
- Sponsor
- Tebao Biotech
- Start
- Jul 2014
- Modality
- PEGylated Peptides → Modified Peptides → Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of telpegfilgrastim in neutropenia, sponsored by Tebao Biotech. Started Jul 2014; status: completed.
02
Drugs
telpegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on CTR20140464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140464.